跳至主要内容
临床试验/NCT02730949
NCT02730949已完成3 期

A Pilot Study of D-Chiro-Inositol Plus Folic Acid in Overweight Patients With Type 1 Diabetes

Campus Bio-Medico University2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2014年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
26
试验地点
2
主要终点
efficacy of DCI oral supplementation on metabolic control

研究概览

简要总结

The purpose of this pilot study was to evaluate the effect of D-chiro-Inositol (DCI) oral supplementation in addiction to folic acid compared to folic acid alone on glycaemic control as assessed by HbA1c in overweight or obese T1D patients undergoing intensive insulin therapy.

A 24 weeks, prospective, randomized control trial was carried out in T1D patients, aged 17-50 years (13 males, 13 females), with disease duration > 1 year and BMI >25, attending as outpatients the Endocrinology and Diabetes Unit of University Campus Bio-Medico in Rome

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
17 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • T1D patients
  • aged 17-50 years
  • disease duration > 1 year

排除标准

  • learning disabilities
  • presence of chronic conditions potentially able to influence daily activities (visual or auditory disability, motor impairment for neurological or orthopaedic problems).
  • T1D patients affected from diabetic complications
  • pregnancy

结局指标

主要结局

efficacy of DCI oral supplementation on metabolic control

时间窗: 6 months

efficacy of DCI oral supplementation on metabolic control as assessed by HbA1c (%)

次要结局

  • BMI kg/m2(6 months)
  • Insulin Requirement (I.R.) IU/kg(6 months)

研究者

发起方
Campus Bio-Medico University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Paolo Pozzilli

Prof

Campus Bio-Medico University

研究点 (2)

Loading locations...

相似试验